Spirometry parameters used to define small airways obstruction in population-based studies: systematic review

Abstract

Background The assessment of small airways obstruction (SAO) using spirometry is practiced in population-based studies. However, it is not clear what are the most used parameters and cut-offs to define abnormal results. Methods We searched three databases (Medline, Web of Science, Google Scholar) for population-based studies, published by 1 May 2021, that used spirometry parameters to identify SAO and/or provided criteria for defining SAO. We systematically reviewed these studies and summarised evidence to determine the most widely used spirometry parameter and criteria for defining SAO. In addition, we extracted prevalence estimates and identified associated risk factors. To estimate a pooled prevalence of SAO, we conducted a meta-analysis and explored heterogeneity across studies using meta regression. Results Twenty-five studies used spirometry to identify SAO. The most widely utilised parameter (15 studies) was FEF25–75, either alone or in combination with other measurements. Ten studies provided criteria for the definition of SAO, of which percent predicted cut-offs were the most common (5 studies). However, there was no agreement on which cut-off value to use. Prevalence of SAO ranged from 7.5% to 45.9%. As a result of high heterogeneity across studies (I2 = 99.3%), explained by choice of spirometry parameter and WHO region, we do not present a pooled prevalence estimate. Conclusion There is a lack of consensus regarding the best spirometry parameter or defining criteria for identification of SAO. The value of continuing to measure SAO using spirometry is unclear without further research using large longitudinal data. PROSPERO registration number CRD42021250206

Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study

“…8 In a review published in 2022, we found little consensus on the best spirometry parameter to use when measuring small airways obstruction. 9 Although FEF 25-75 is the most popular parameter, it is limited by high between-person variability, 10 whereas the FEV 3 /FVC ratio is a more suitable alternative, but it is scarcely used. 11 The rationale behind identifying small airways obstruction is its potential to act as a modifiable precursor to future obstructive lung disease.…”

Small airway dysfunction is an early physiological characteristic of idiopathic pulmonary fibrosis : a retrospective cohort study

“…Spirometry parameters re ecting small airway function include FEV1, FEV 3 /FVC, MMEF, MEF50%, MEF25% [22,23]. Based on the Guideline for pulmonary function testing in primary care (2018) published by the Chinese Medical Association (CMA) and previous studies, SAD was diagnosed when at least two of these three indicators (MMEF, MEF50%, MEF25%) were less than 65% of predicted values in this study [23][24][25][26][27][28]. By spirometry, we identi ed that about 40% of IPF patients presented SAD signi cantly more frequently than the control group (21.0%).…”

Effectiveness of glycopyrronium bromide in the treatment of small airway dysfunction: A retrospective study

“…As a measure of airflow limitation, FEF 25–75 is highly correlated with FEV 1 /FVC ratio, but non-linearly, so that FEF 25–75 decreases more steeply than FEV 1 /FVC at mild obstruction levels. We considered a FEV 1 /FVC ratio <70% as a marker of obstruction, 11 a FEF 25–75 <60% of predicted value as an expression of small airway dysfunction, 12 and an increase in RV/TLC ratio >20% as an indicator of lung hyperinflation. All subjects who exhibited a FEF 25–75 reduction, a normal FEV 1 /FVC ratio, and an increased RV/TLC ratio with symptoms of dyspnea upon exertion, were treated with a bronchodilator therapy consisting of GB at the dosage of 50 μg once a day for 4 months.…”